Liver Health ECHO Program 2025 Session #2: MASLD and CoMorbidities

Be part of the solution. Liver disease affects millions, yet remains underdiagnosed and undertreated. Through the Project ECHO Liver Health Program, you can: Expand your expertise in diagnosing and managing MASLD/MASH Connect with leading hepatologists and a nationwide network of peers Empower your practice with evidence-based tools and case-based learning Transform patient outcomes in your community. Don’t wait—join the ECHO sessions and become a champion for liver health. Register now and help build a healthier future, one liver at a time: https://alf.social/ECHOpc2 On this video, we are joined our presenters: Albert Do, MD, MPH Case Study with Samuel Shao-Guang Ji, DO To learn more about ALF's Think Liver Think Life program, please visit our website at https://thinkliverthinklife.org/ For more information about the American Liver Foundation, visit https://liverfoundation.org/. To join our mail list visit https://liver.news/llwmail. If you've liked what you've seen on this video, then please consider clicking the red "Subscribe" button to be notified when new videos from the American Liver Foundation are posted. Click "Like" and "Share" this with your friends. Leave a comment below. The nomenclature for nonalcoholic fatty liver disease (NAFLD) has recently changed to metabolic dysfunction associated steatotic liver disease (MASLD). Nonalcoholic steatohepatitis (NASH) has been renamed to metabolic dysfunction associated steatohepatitis (MASH). Fatty liver disease is now called steatotic liver disease. Thank you.